Dow Down 0.32% Nasdaq Down 0.62%

More On HBMK

Quotes

Charts

News & Info

Company

  • Profile
  • Key Statistics
  • SEC Filings
  • Competitors
  • Industry
  • Components

Analyst Coverage

Ownership

Financials

Hubei Minkang Pharmaceutical Ltd (HBMK)

-Other OTC
1.00 0.00(0.00%) N/A
Prev Close:1.00
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:4.3403
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:1.00 - 1.00
Volume:0
Avg Vol (3m):0
Market Cap:52.19M
P/E (ttm):N/A
EPS (ttm):-0.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for HBMK at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hubei Minkang Pharmaceutical Ltd. is engaged in the research, development, manufacture, and marketing of traditional Chinese medicine (TCM) and chemical pharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback